A group of medical professionals that advocates against “radical, divisive, and discriminatory ideology” in healthcare sued Pfizer Inc. on Thursday, saying the drugmaker runs a fellowship that illegally excludes white and Asian-American applicants.
https://www.pharmalive.com/wp-content/uploads/2022/05/Pfizer-keeps-COVID-sales-forecast-unchanged-as-pandemic-curbs-ease-Reuters-5-3-22.webp503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-15 18:57:472022-09-16 11:21:56Lawsuit claims Pfizer fellowship program is biased against whites, Asian-Americans